| Sylentis S.A. Patent applications |
| Patent application number | Title | Published |
|---|
| 20090264501 | Methods and Compositions to Inhibit P2x7 Receptor Expression - Methods and compositions for the downregulation of P2X7 receptor expression or activity are disclosed. Preferred compositions comprise siNA. The methods and compositions are useful in the treatment of diseases characterised by increased 112X7 receptor activity, such as neuronal degeneration, Alzheimer's disease, inflammatory diseases, and some cancers. | 10-22-2009 |
| 20090176728 | Treatment of CNS Conditions - Methods and compositions for the treatment of pathologic conditions of the central nervous system (CNS) by means of intranasal administration of a composition that modulates, by means of RNA interference, the expression and/or activity of genes involved in above-mentioned conditions. | 07-09-2009 |
| 20090005330 | Methods and Compositions to Inhibit P2x7 Receptor Expression - Methods and compositions for the downregulation of P2X7 receptor expression or activity are disclosed. Preferred compositions comprise siNA. The methods and compositions are useful in the treatment of diseases characterised by increased 112X7 receptor activity, such as neuronal degeneration, Alzheimer's disease, inflammatory diseases, and some cancers. | 01-01-2009 |
